ESC Premium Access

Interpreting clinical trials: does a primary endpoint tell it all?

Event: ESC CONGRESS 2016
Topic: Guidelines and implementation in low resource settings
Session type: Symposium
Date: 29 August 2016
Time: 08:30 - 10:00

Session

4 presentations in this session

Primary endpoint is negative, what next? A clinical perspective.

Speaker: Professor M. Pfeffer (Boston, US)
Thumbnail

Primary endpoint is negative, what next? A statistical perspective.

Speaker: Professor S. Pocock (London, GB)
Thumbnail

Primary endpoint is positive, is that enough? A clinical perspective.

Speaker: Doctor G. Stone (New York, US)
Thumbnail

Primary endpoint is positive, is that enough? A statistical perspective.

Speaker: Professor P. Juni (Toronto, CA)
Thumbnail

4 speakers from this session

Professor Marc Pfeffer

Brigham And Women'S Hospital, Harvard Medical School, Boston (United States of America)
23 presentations
0 follower

Professor Stuart J Pocock

London School of Hygiene and Tropical Medicine, London (United Kingdom of Great Britain & Northern Ireland)
8 presentations
0 follower

Doctor Gregg Stone

Icahn School of Medicine at Mount Sinai, New York (United States of America)
12 presentations
0 follower

Professor Peter Juni

St. Michael's Hospital, Toronto (Canada)
5 presentations
0 follower

This platform is supported by

logo Novo Nordisk